MDS Pharma Services

MDS Pharma Services

March 03, 2005 19:03 ET

MDS Pharma Services to Host Grand Opening of Expanded Singapore Facility


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: MDS PHARMA SERVICES

TSX SYMBOL: MDS
NYSE SYMBOL: MDZ

MARCH 3, 2005 - 19:03 ET

MDS Pharma Services to Host Grand Opening of Expanded
Singapore Facility

MONTREAL, QUEBEC--(CCNMatthews - March 3, 2005) - MDS Pharma Services, a
leading provider of innovative drug discovery and development solutions,
will host a grand opening event for its newly expanded Singapore
facility. This expansion houses MDS Pharma Services' growing presence in
Singapore, which currently includes central lab and ECG study
coordination services, logistics and global clinical development
services. Keynote speaker for the grand opening program will be Andy
Lee, Senior Director, Cardiovascular and Metabolic Diseases, Pfizer
Global Research and Development, who will discuss "The Global Nature of
Clinical Trials: Emergence of Asia as a Key Player."



WHAT: Grand opening ceremony for MDS Pharma Services' expanded
Singapore facility including ribbon-cutting ceremony,
lab tours, gala dinner and keynote speaker

WHEN: Monday, April 11, 2005
Press Conference at 2:30 PM

WHERE: 2 International Business Park
#10-06, Tower 1, The Strategy
Singapore 609930


Individuals interested in attending this grand opening event are
encouraged to view the complete agenda online at
www.mdsps.com/events/singapore2005.htm. Registration is available on
that Web page or via e-mail at Singapore.launch@mdsps.com.

MDS Pharma Services offers a full spectrum of resources to meet the drug
discovery and development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around the
world, the company applies advanced scientific and technological
expertise to each stage of the drug discovery and development process -
early stage: lead optimization, pre-IND research, pharmaceutical and
biopharmaceutical development, early clinical research (bioequivalence,
phases I-IIa) and bioanalysis; and late stage: global clinical
development (phases IIb-IV) and central lab. For more information, visit
MDS Pharma Services' Web site at www.mdsps.com.

MDS Pharma Services is an integral part of MDS Inc. (TSX:MDS)(NYSE:MDZ).
MDS Inc. has more than 9,000 highly skilled people in 25 countries
providing a diverse range of superior products and services to increase
our customers' speed, precision and productivity in the drug development
and disease diagnosis processes. We are a global health and life
sciences company, recognized for our reliability and collaborative
relationships. Please refer to our website at www.mdsintl.com to find
out more about how we help create better outcomes in the treatment of
disease.

For further information regarding the event, please contact Raymond
Yeung, MDS Pharma Services, 2 International Business Park, #10-06, Tower
1, The Strategy, Singapore 609930, Tel: +65-6896-5301.


-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    MDS Pharma Services
    For Media Inquiries:
    Kim Peacock
    (402) 476-2811
    621 Rose Street, Lincoln Neb.
    www.mdsps.com